These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
x
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
o
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
Texas
|
93-1216127
|
|
|
(State or other jurisdiction of
|
(I.R.S. Employer
|
|
|
incorporation or organization)
|
Identification No.) |
|
Large accelerated filer
|
o |
Accelerated filer
|
o |
|
Non-accelerated filer
|
o |
Smaller reporting company
|
x |
|
(Do not check if a smaller reporting company)
|
|
Class
|
Outstanding at October 1, 2013
|
|
|
Common Stock, par value $.10 per share
|
15,536,275 shares
|
|
Page(s)
|
|||||
|
PART I
|
Financial Information:
|
||||
|
ITEM 1
|
Financial Statements:
|
||||
|
Condensed Balance Sheets (unaudited) —March 31, 2012 and December 31, 2011
|
3
|
||||
|
Condensed Statements of Operations (Unaudited) - Cumulative Period During the Development Stage (January 1, 1999 to March 31, 2012) and the Three Months Ended March 31, 2012 and 2011
|
4
|
||||
|
Condensed Statements of Cash Flows (Unaudited) - Cumulative Period During the Development Stage (January 1, 1999 to March 31, 2012) and the Three Months Ended March 31, 2012 and 2011
|
5
|
||||
|
Notes to Interim Condensed Financial Statements (Unaudited)
|
6 -14
|
||||
|
ITEM 2
|
Management’s Discussion and Analysis of Financial Condition and Results of Operations
|
15
|
|||
|
ITEM 3
|
Quantitative and Qualitative Disclosures About Market Risk
|
16
|
|||
|
ITEM 4
|
Controls and Procedures
|
16
|
|||
|
PART II
|
Other Information
|
||||
|
ITEM 1.
|
Legal Proceedings.
|
18
|
|||
|
ITEM 2.
|
Unregistered Sales of Equity Securities and Use of Proceeds.
|
18
|
|||
|
ITEM 3.
|
Defaults upon Senior Securities.
|
18
|
|||
|
ITEM 4.
|
Mine Safety Disclosures.
|
18
|
|||
|
ITEM 5.
|
Other Information.
|
18
|
|||
|
ITEM 6.
|
Exhibits.
|
19
|
|||
|
SIGNATURES
|
20
|
||||
|
EXHIBITS
|
|||||
|
March 31,
|
December 31,
|
|||||||
|
2012
|
2011
|
|||||||
|
ASSETS
|
||||||||
|
CURRENT ASSETS:
|
||||||||
|
Cash
|
$ | 1,471,979 | $ | 1,484,906 | ||||
|
TOTAL ASSETS
|
$ | 1,471,979 | $ | 1,484,906 | ||||
|
LIABILITIES, PREFERRED STOCK AND STOCKHOLDERS’ DEFICIT-
|
||||||||
|
CURRENT LIABILITIES:
|
||||||||
|
Accounts payable and accrued expenses
|
$ | 26,384 | $ | 9,174 | ||||
|
Warrant liability
|
36,826 | 70,991 | ||||||
|
TOTAL CURRENT LIABILITIES
|
63,210 | 80,165 | ||||||
|
COMMITMENTS AND CONTINGENCIES
|
- | - | ||||||
|
PREFERRED STOCK,
$1.00 par value; 4,000,000 authorized: Series A 10% Convertible Preferred stock; 50,000 shares authorized; 20,637 and 20,637 shares issued and outstanding as of March 31, 2012 and December 31, 2011, respectively: liquidation preference of $2,063,700 and $2,063,700 as of March 31, 2012 and December 31, 2011, respectively
|
1,985,181 | 1,951,846 | ||||||
|
STOCKHOLDERS’ DEFICIT:
|
||||||||
|
Common stock, $.10 par value 200,000,000 shares authorized; 15,536,275 shares issued and outstanding as of March 31, 2012 and December 31, 2011
|
1,553,628 | 1,553,628 | ||||||
|
Additional paid-in capital
|
2,559,145 | 2,559,145 | ||||||
|
Accumulated deficit
|
(3,626,121 | ) | (3,626,121 | ) | ||||
|
Deficit accumulated during the development stage
|
(1,063,064 | ) | (1,033,757 | ) | ||||
|
TOTAL STOCKHOLDERS’ DEFICIT
|
(576,412 | ) | (547,105 | ) | ||||
|
TOTAL LIABILITIES, PREFERRED STOCK AND STOCKHOLDERS’ DEFICIT
|
$ | 1,471,979 | $ | 1,484,906 | ||||
|
For The Three Month
Ended
March 31,
|
Cumulative
During the
Development
Stage
(January
1, 1999
to March
|
|||||||||||
|
2012
|
2011
|
31, 2012)
|
||||||||||
|
(Restated)
|
(Restated)
|
|||||||||||
|
NET SALES
|
$ | - | $ | - | $ | - | ||||||
|
EXPENSES:
|
||||||||||||
|
General and administrative expense
|
30,175 | 22,210 | 629,086 | |||||||||
|
LOSS FROM OPERATIONS
|
(30,175 | ) | (22,210 | ) | (629,086 | ) | ||||||
|
OTHER INCOME (EXPENSE)
|
||||||||||||
|
Interest expense
|
- | - | (8,591 | ) | ||||||||
|
Interest and other income
|
38 | 198 | 59,921 | |||||||||
|
Change in warrant liability
|
34,165 | 28,956 | 104,202 | |||||||||
|
TOTAL OTHER INCOME (EXPENSE)
|
34,203 | 29,154 | 155,532 | |||||||||
|
INCOME/(LOSS) BEFORE INCOME TAXES
|
4,028 | 6,944 | (473,554 | ) | ||||||||
|
Provision for income taxes
|
- | - | - | |||||||||
|
NET INCOME/(LOSS)
|
$ | 4,028 | $ | 6,944 | $ | (473,554 | ) | |||||
|
Accretion of preferred stock to redemption value
|
(33,335 | ) | (33,335 | ) | (589,510 | ) | ||||||
|
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS
|
$ | (29,307 | ) | $ | (26,391 | ) | $ | (1,063,064 | ) | |||
|
BASIC AND DILUTED LOSS PER COMMON SHARE
|
$ | (0.00 | ) | $ | (0.00 | ) | ||||||
|
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING – BASIC AND DILUTED
|
15,536,275 | 15,536,275 | ||||||||||
|
For The Three Months
Ended
March 31,
|
Cumulative
During the
Development
Stage
(January
1,
1999
to March
|
|||||||||||
|
2012
|
2011
|
31, 2012)
|
||||||||||
|
(restated)
|
(Restated)
|
|||||||||||
|
CASH FLOWS FROM OPERATING ACTIVITIES:
|
||||||||||||
|
Net income (loss)
|
$ | 4,028 | $ | 6,944 | $ | (473,554 | ) | |||||
|
Adjustment to reconcile to net loss to net cash used in operating activities:
|
||||||||||||
|
Change in warrant liability
|
(34,165 | ) | (28,956 | ) | (104,202 | ) | ||||||
|
Change in assets and liabilities:
|
||||||||||||
|
Accounts payable and accrued expenses
|
17,210 | 13,387 | 11,206 | |||||||||
|
Net cash used in operating activities
|
(12,927 | ) | (8,625 | ) | (566,550 | ) | ||||||
|
CASH FLOWS FROM INVESTING ACTIVITIES
|
- | - | - | |||||||||
|
CASH FLOWS FROM FINANCING ACTIVITIES
|
||||||||||||
|
Proceeds from convertible debt
|
- | - | 56,500 | |||||||||
|
Proceeds from private placement/exercise of stock warrants
|
- | - | 5,500 | |||||||||
|
Capital contribution
|
- | - | 8,000 | |||||||||
|
Proceeds from private placement
|
- | - | 1,962,358 | |||||||||
|
Cash dividends paid on preferred stock
|
- | - | (5,490 | ) | ||||||||
|
Net cash provided by financing activities
|
- | - | 2,026,868 | |||||||||
|
NET INCREASE (DECREASE) IN CASH
|
(12,927 | ) | (8,625 | ) | 1,460,318 | |||||||
|
Cash, at beginning of period
|
1,484,906 | 1,581,989 | 11,661 | |||||||||
|
CASH, END OF PERIOD
|
$ | 1,471,979 | $ | 1,573,364 | $ | 1,471,979 | ||||||
|
SUPPLEMENTAL CASH FLOW INFORMATION:
|
||||||||||||
|
Cash paid for:
|
||||||||||||
|
Interest
|
$ | - | $ | - | $ | - | ||||||
|
Income taxes
|
$ | - | $ | - | $ | - | ||||||
|
SUPPLEMENTAL DISCLOSURE OF NON-CASH FINANCING ACTIVITIES:
|
||||||||||||
|
Accretion of preferred stock to redemption value
|
$ | 33,335 | $ | 33,335 | $ | 589,510 | ||||||
|
Preferred stock issued as stock dividend
|
$ | - | $ | - | $ | 6,820 | ||||||
|
416 Private Placement Units were issued in exchange for $56,500 of convertible notes plus $5,900 of accrued interest
|
$ | - | $ | - | $ | 62,400 | ||||||
|
68 Private Placement Units were issued in exchange for $8,000 of stock subscriptions plus $2,200 of accrued interest
|
$ | - | $ | - | $ | 10,200 | ||||||
|
BALANCE SHEET AS OF MARCH 31, 2011
|
||||||||||||
|
As Previously
Reported
|
Effect of
Restatement
|
As
restated
|
||||||||||
|
Warrant liability
|
$ | - | $ | 58,284 | $ | 58,284 | ||||||
|
Redeemable and convertible preferred stock
(under mezzanine)
|
$ | - | $ | 1,849,978 | $ | 1,849,978 | ||||||
|
Preferred Stock
|
$ | 18,775 | $ | (18,775 | ) | $ | - | |||||
|
Common stock
|
$ | 1,553,628 | $ | - | $ | 1,553,628 | ||||||
|
Additional paid-in capital
|
$ | 4,077,068 | $ | (1,516,060 | ) | $ | 2,561,008 | |||||
|
Accumulated deficit
|
$ | (3,626,121 | ) | $ | - | $ | (3,626,121 | ) | ||||
|
Deficit accumulated during the development stage
|
$ | (464,761 | ) | $ | (373,427 | ) | $ | (838,188 | ) | |||
|
Stockholders' equity (deficit)
|
$ | 1,558,589 | $ | (1,908,262 | ) | $ | (349,673 | ) | ||||
|
STATEMENT OF OPERATIONS FOR THE THREE MONTHS ENDED MARCH 31, 2011
|
||||||||||||
|
As Previously
Reported
|
Effect of
Restatement
|
As
restated
|
||||||||||
|
Change in warrant liability expense
|
$ | - | $ | 28,956 | $ | 28,956 | ||||||
|
Net (loss) income for the period
|
$ | (22,012 | ) | $ | 28,956 | $ | 6,944 | |||||
|
Accretion of preferred stock to redemption value
|
$ | - | $ | (33,335 | ) | $ | (33,335 | ) | ||||
|
Net loss attributable to common stockholders
|
$ | (22,012 | ) | $ | (4,379 | ) | $ | (26,391 | ) | |||
|
Net loss per share – basic and diluted attributable to common stockholders
|
$ | - | $ | (0.00 | ) | $ | (0.00 | ) | ||||
|
STATEMENT OF OPERATIONS FROM JANUARY 1, 1999 (INCEPTION) TO MARCH 31, 2011
|
|||||||||||||
|
As Previously
Reported
|
Effect of
Restatement
|
As
restated
|
|||||||||||
|
Change in warrant liability expense
|
$ | - | $ | 82,743 | $ | 82,743 | |||||||
|
Net (loss) income for the period
|
$ | (464,761 | ) | $ | 82,743 | $ | (382,018 | ) | |||||
|
Accretion of preferred stock to redemption value
|
$ | - | $ | (456,170 | ) | $ | (456,170 | ) | |||||
|
Net loss attributable to common stockholders
|
$ | (464,761 | ) | $ | (373,427 | ) | $ | (838,188 | ) | ||||
|
STATEMENT OF CASH FLOWS FOR THE THREE MONTHS ENDED MARCH 31, 2011
|
||||||||||||
|
As Previously
Reported
|
Effect of
Restatement
|
As
restated
|
||||||||||
|
Net (loss) income
|
$ | (22,012 | ) | $ | 28,956 | $ | 6,944 | |||||
|
Change in warrant liability
|
$ | - | $ | (28,956 | ) | $ | (28,956 | ) | ||||
|
Net cash used in operating activities
|
$ | (8,625 | ) | $ | - | $ | (8,625 | ) | ||||
|
STATEMENT OF CASH FLOWS FROM JANUARY 1, 1999 (INCEPTION) TO MARCH 31, 2011
|
||||||||||||
|
As Previously
Reported
|
Effect of
Restatement
|
As restated
|
||||||||||
|
Net (loss) income
|
$ | (464,761 | ) | $ | 82,743 | $ | (382,018 | ) | ||||
|
Change in warrant liability
|
$ | - | $ | (82,743 | ) | $ | (82,743 | ) | ||||
|
Net cash used in operating activities
|
$ | (465,165 | ) | $ | - | $ | (465,165 | ) | ||||
|
Warrant liabilities
|
$ | 141,027 | ||
|
Redeemable and Convertible Preferred Stock
|
1,388,367 | |||
|
Common Stock
|
470,706 | |||
|
Total allocated gross proceeds:
|
$ | 2,000,100 |
|
2012
|
2011
|
|||||||||||||||
|
Number of
warrants
|
Weighted average exercise price
|
Number of
warrants
|
Weighted average exercise price
|
|||||||||||||
|
Balance at January 1
|
6,909,000 | $ | 0.15 | 6,909,000 | $ | 0.15 | ||||||||||
|
Issued during the period
|
- | $ | - | - | $ | - | ||||||||||
|
Exercised during the period
|
- | $ | - | - | $ | - | ||||||||||
|
Expired during the period
|
- | $ | - | - | $ | - | ||||||||||
|
Balance at March 31
|
6,909,000 | $ | 0.15 | 6,909,000 | $ | 0.15 | ||||||||||
|
Fair values
|
March 31,
2012
|
December 31,
2011
|
At transaction
date
|
|||||||||
|
September 7, 2007 financing
|
$ | 36,826 | $ | 70,991 | $ | 141,027 | ||||||
|
March 3
1,
2012
|
December 31,
2011
|
At transaction
date
|
||||||||||
|
Warrants outstanding
|
6,909,000 | 6,909,000 | 6,909,000 | |||||||||
|
Exercise price
|
$ | 0.15 | $ | 0.15 | $ | 0.15 | ||||||
|
Annual dividend yield
|
0.03 | % | 0.03 | % | 4.01 | % | ||||||
|
Expected life (years)
|
0.44 | 0.69 | 5 | |||||||||
|
Risk-free interest rate
|
0.12 | % | 0.12 | % | 4.14 | % | ||||||
|
Expected volatility
|
69 | % | 77 | % | 53.94 | % | ||||||
|
Carrying
Amount In
Balance Sheet
March 31,
|
Fair Value
March 31,
|
Fair Value Measurement Using | ||||||||||||||||||
|
2012
|
2012
|
Level 1
|
Level 2
|
Level 3
|
||||||||||||||||
|
Assets:
|
||||||||||||||||||||
|
Money Market Funds
|
$ | 1,472,000 | $ | 1,472,000 | $ | 1,472,000 | $ | — | $ | — | ||||||||||
|
Liabilities:
|
||||||||||||||||||||
|
Warrant Liability
|
$ | 37,000 | $ | 37,000 | $ | — | $ | — | $ | 37,000 | ||||||||||
|
Carrying
Amount In
Balance
Sheet
December 31,
|
Fair Value
December 31,
|
Fair Value Measurement Using
|
||||||||||||||||||
|
2011
|
2011
|
Level 1 |
Level 2
|
Level 3
|
||||||||||||||||
|
Assets:
|
||||||||||||||||||||
|
Money Market Funds
|
$ | 645,000 | $ | 645,000 | $ | 645,000 | $ | — | $ | — | ||||||||||
|
Treasury Bills
|
$ | 840,000 | $ | 840,000 | $ | 840,000 | $ | — | $ | — | ||||||||||
|
Total Assets:
|
$ | 1,485,000 | $ | 1,485,000 | $ | 1,485,000 | $ | — | $ | — | ||||||||||
|
Liabilities:
|
||||||||||||||||||||
|
Warrant liability
|
$ | 71,000 | $ | 71,000 | $ | — | $ | — | $ | 71,000 | ||||||||||
|
Balance,
beginning
of period
|
Net
realized
gains/
(losses)
|
Net unrealized
gains/(losses)
relating to
instruments
still held at
period-end
|
Purchases
|
Sales
|
Modification on warrants to change to equity
|
Transfers
into
level 3
|
Transfers
out of
level 3
|
Balance,
end of
period
|
||||||||||||||||||||||||||
| $ | 71,000 | - | $ | 34,000 | - | - | - | - | - | $ | 37,000 | |||||||||||||||||||||||
|
Balance,
beginning
of year
|
Net
realized
gains/
(losses)
|
Net unrealized
gains/(losses)
relating to
instruments
still held at
year-end
|
Purchases
|
Sales
|
Modification on warrants to change to equity
|
Transfers
into
level 3
|
Transfers
out of
level 3
|
Balance,
end of
year
|
||||||||||||||||||||||||||
| $ | 87,000 | - | $ | 16,000 | - | - | - | - | - | $ | 71,000 | |||||||||||||||||||||||
|
l
|
Extend the term of the warrants from September 7, 2012 to September 7, 2014.
|
|
l
|
Remove the contingent put feature contained in Section 9(c) which would provide the holder of the Warrant a right to “put” in the event of a fundamental transaction as defined in the agreement (contingent put).
|
|
l
|
Remove the “down round” protection contained in Section 9(d).
|
|
Item 4.
|
|
l
|
We have designed new controls to help ensure that we adopt new accounting guidance with respect to non-routine transactions in a timely manner;
|
|
l
|
We have hired additional accounting personnel and brought previously outsourced administrative accounting functions in-house to ensure additional continuity among all company transactions and accounting functions.
|
|
Item 1.
|
|
|
None.
|
|
|
Item 2.
|
|
|
None.
|
|
|
Item 3.
|
|
|
None.
|
|
|
Item 4.
|
|
|
Not applicable.
|
|
|
Item 5.
|
|
|
None.
|
| Item 6. | Exhibits . |
| Number | Description | |
| 4.1 | Form of Agreement dated March 30, 2012, among the Company and various holders of Chase Packaging Corporation’s Series A 10% Convertible Preferred Stock, filed as Exhibit 10.1 to the Company’s Form 8-K filed with the Securities and Exchange Commission on April 5, 2012, and incorporated herein by reference. | |
| 4.2 |
Form of Amendment No. 1 to Warrant Agreement dated to be effective June 30, 2012, filed as Exhibit 4.1 to the Company’s Form 8-K filed with the Securities and Exchange Commission on July 5, 2012, and incorporated herein by reference.
|
|
| 4.3 |
Statement of Resolution Regarding Series of Preferred Stock of the Company, filed as Exhibit 4.1 to the Company’s Form 8-K filed with the Securities and Exchange Commission on September 10, 2012, and incorporated herein by reference.
|
|
| 31.1* | Certification of the Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | |
| 31.2* | Certification of the Principal Financial and Accounting Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | |
| 32.1* | Certification of the Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | |
| 32.2* | Certification of the Principal Financial and Accounting Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | |
| 101 | Financial Statements from the quarterly report on Form 10-Q of Chase Packaging Corporation for the quarter ended March 31, 2012, filed on October 11, 2013, formatted in XBRL: (i) the Condensed Balance Sheets (Unaudited); (ii) the Condensed Statements of Operations (Unaudited); (iii) the Condensed Statements of Cash Flows (Unaudited); and (iv) the Notes to Interim Condensed Financial Statements (Unaudited) tagged as blocks of text. |
|
CHASE PACKAGING CORPORATION
|
||
|
Date: October 11, 2013
|
/s/ Allen T. McInnes
|
|
|
Allen T. McInnes
|
||
|
Chairman of the Board, President and Treasurer
|
||
|
(Principal Executive Officer)
|
||
|
Date: October 11, 2013
|
/s/ Ann C. W. Green
|
|
|
Ann C. W. Green
|
||
|
Chief Financial Officer and Assistant Secretary
|
||
|
(Principal Financial and Accounting Officer)
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|